IP Library Granted Patent US 7,615,547
Granted Patent B2
US 7,615,547 · App. 10/258,004 · Granted Nov 10, 2009

Granulates containing liposoluble substances and a process for the preparation thereof

Assignees: APR Applied Pharma Research SA; Fidia Farmaceutici SpA; Ipsen SpA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,547
App. No.
10/258,004
Granted
Nov 10, 2009
Kind
B2
Abstract

A process is described for the preparation of granulates that contain liposoluble and hydrophobic substances, preferably steroidal substances, and that exhibit rapid and excellent water-dispersibility. The process comprises: a) the dispersion of substance (A) in water in the presence of a surfactant (B), b) the incorporation of a water-soluble polyhydroxylated solid excipient (C) in the aqueous dispersion until a granulable pasty mass is obtained and c) the granulation of the mass. The granulates so obtained are suitable for the preparation, at the time of use, of stable and homogeneous aqueous suspensions that are used for nutritional, cosmetic or, preferably, pharmaceutical purposes.

Claims (34)

1. A process for preparing a liquid suspension which is stable at the time of use, which process comprises:

a) dispersing a liposoluble and hydrophobic substance having a water-solubility at 20° C. of less than 20 μg/ml in a medium consisting of water and a surfactant to create an aqueous dispersion, wherein the liposoluble and hydrophobic substance is a steroidal substance and wherein the dispersion is effected at a temperature of from 20° C. to 60° C.;

b) incorporating a water-soluble polyhydroxylated solid excipient in the aqueous dispersion and therein obtaining a granulable pasty mass;

c) granulating the pasty mass; and

d) placing the thus-obtained granulate in an aqueous medium;

wherein the amount of surfactant, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 0.013 to 0.7;

wherein the amount of water, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 0.2 to 1; and

wherein the amount of polyhydroxylated solid excipient, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 1 to 6.

2. A process according to claim 1 , wherein the liposoluble and hydrophobic substance is megestrol acetate.

3. A process according to claim 1 , wherein the surfactant is a polysorbate.

4. A process according to claim 3 , wherein the surfactant is polysorbate 80.

5. A process according to claim 1 , wherein the dispersion of the liposoluble and hydrophobic substance in water is effected at a temperature of from 25° C. to 40° C.

6. A process according to claim 1 , wherein the water-soluble polyhydroxylated solid excipient is selected from the group consisting of: mannitol, sorbitol, lactose, fructose and mixtures thereof.

7. A process according to claim 1 ,

wherein the amount of surfactant, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 0.02 to 0.33; and

wherein the amount of polyhydroxylated solid excipient, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 3 to 5.

8. A process according to claim 1 , wherein the amount of water, by weight, relative to liposoluble and hydrophobic substance, is from 0.5 to 0.7.

9. A liquid suspension which is stable at the time of use which is produced by the process according to claim 1 .

10. A process for preparing a liquid suspension which is stable at the time of use, the process comprising the steps of:

a) dispersing a liposoluble and hydrophobic substance having a water-solubility at 20° C. of less than 20 μg/ml in a medium consisting of water and a polysorbate to create an aqueous dispersion, wherein the liposoluble and hydrophobic substance is a steroidal substance and wherein the dispersion is effected at a temperature of from 20° C. to 60° C.;

b) incorporating a water-soluble polyhydroxylated solid excipient in the aqueous dispersion and therein obtaining a granulable pasty mass, wherein the water-soluble polyhydroxylated solid excipient is selected from the group consisting of: mannitol, sorbitol, lactose, fructose and mixtures thereof;

c) granulating the pasty mass; and

d) placing the thus-obtained granulate in an aqueous medium;

wherein the amount of surfactant, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 0.013 to 0.7;

wherein the amount of water, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 0.2 to 1; and

wherein the amount of polyhydroxylated solid excipient, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 1 to 6.

11. A process according to claim 10 , wherein the liposoluble and hydrophobic substance is megestrol acetate.

12. A process according to claim 10 , wherein the polysorbate is polysorbate 80.

13. A process according to claim 10 , wherein the dispersion of the liposoluble and hydrophobic substance in water is effected at a temperature of from 25° C. to 40° C.

14. A process according to claim 10 ,

wherein the amount of surfactant, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 0.02 to 0.33; and

wherein the amount of polyhydroxylated solid excipient, by weight, relative to the amount of liposoluble and hydrophobic substance, is from 3 to 5.

15. A process according to claim 10 wherein the amount of water, by weight, relative to liposoluble and hydrophobic substance, is from 0.5 to 0.7.

16. A liquid suspension which is stable at the time of use which is produced by process the process according to claim 10 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2004
From: REINER, ALBERTO
To: APR APPLIED PHARMA RESEARCH SA; FIDIA FARMACEUTICI SPA; IPSEN SPA
Reel/Frame 015067/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2003
From: REINER, ALBERTO
To: APR APPLIED PHARMA RESEARCH SA; FIDIA PARMACEUTICI S.P.A.; IPSEN SPA
Reel/Frame 014323/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2003
From: REINER, ALBERTO
To: APR APPLIED PHARMA RESEARCH SA; FIDIA PARMACEUTICI S.P.A.; IPSEN SPA
Reel/Frame 013855/0113 →
Continuity (1)
Related Publication 20040009232A1 · Jan 15, 2004